 BOSTON, Jan. 05, 2023 GLOBE NEWSWIRE AVEO Oncology AVEO Nasdaq: AVEO, a commercial stage, oncology-focused biopharmaceutical company committed to delivering medicines that provide a better life for patients with cancer, announced that at a special meeting of stockholders the Special Meeting held today, AVEO stockholders approved the adoption of the Agreement and Plan of ... The post AVEO Oncology Stockholders Approve Acquisition by LG Chem appeared first on ForexTV... 